Avoid BPC-157 When Cancer Risk Is a Concern

This recommendation is to avoid or be very cautious with BPC-157 when you have a known tumor, a cancer history, or heightened cancer concern. The rationale is that BPC-157 may increase VEGF and angiogenesis, which could theoretically support tumor growth or work against anti-cancer strategies, so it should not be used casually in these settings.